Kelly DL - Search Results

1

25-Hydroxyvitamin D and metabolic-related laboratory values in women with schizophrenia and hyperprolactinemia.

Nallani MC, Powell MM, Pugh S, Kearns AM, Adams HA, Weiner E, Wehring HJ, McEvoy JP, Buckley PF, Liu F, Buchanan RW, Kelly DL. Nallani MC, et al. Among authors: kelly dl. J Psychiatr Res. 2022 Jul;151:25-29. doi: 10.1016/j.jpsychires.2022.03.046. Epub 2022 Apr 8. J Psychiatr Res. 2022. PMID: 35429802

2

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

Kelly DL, Nelson MW, Love RC, Yu Y, Conley RR. Kelly DL, et al. Psychiatr Serv. 2001 May;52(5):676-8. doi: 10.1176/appi.ps.52.5.676. Psychiatr Serv. 2001. PMID: 11331805

3

Deaths from diabetic ketoacidosis after long-term clozapine treatment.

Wehring HJ, Kelly DL, Love RC, Conley RR. Wehring HJ, et al. Among authors: kelly dl. Am J Psychiatry. 2003 Dec;160(12):2241-2. doi: 10.1176/appi.ajp.160.12.2241-a. Am J Psychiatry. 2003. PMID: 14638600 No abstract available.

4

Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death.

Kelly DL, Shim JC, Feldman SM, Yu Y, Conley RR. Kelly DL, et al. J Psychiatr Res. 2004 Sep-Oct;38(5):531-6. doi: 10.1016/j.jpsychires.2004.02.001. J Psychiatr Res. 2004. PMID: 15380404

5

First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Kelly DL, Conley RR, Carpenter WT. Kelly DL, et al. Drugs. 2005;65(8):1113-38. doi: 10.2165/00003495-200565080-00006. Drugs. 2005. PMID: 15907146 Review.

6

Sexuality and schizophrenia: a review.

Kelly DL, Conley RR. Kelly DL, et al. Schizophr Bull. 2004;30(4):767-79. doi: 10.1093/oxfordjournals.schbul.a007130. Schizophr Bull. 2004. PMID: 15954189 Review.

7

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Kelly DL, et al. Psychiatr Q. 2006 Spring;77(1):81-95. doi: 10.1007/s11126-006-7963-9. Psychiatr Q. 2006. PMID: 16397757

8

Treatment considerations in women with schizophrenia.

Kelly DL. Kelly DL. J Womens Health (Larchmt). 2006 Dec;15(10):1132-40. doi: 10.1089/jwh.2006.15.1132. J Womens Health (Larchmt). 2006. PMID: 17199454 Review.

9

Reaching for wellness in schizophrenia.

Kelly DL, Boggs DL, Conley RR. Kelly DL, et al. Psychiatr Clin North Am. 2007 Sep;30(3):453-79. doi: 10.1016/j.psc.2007.04.003. Psychiatr Clin North Am. 2007. PMID: 17720032 Review.

10

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.

Kelly DL, McMahon RP, Weiner E, Boggs DL, Dickinson D, Conley RR, Buchanan RW. Kelly DL, et al. Schizophr Res. 2008 Aug;103(1-3):161-8. doi: 10.1016/j.schres.2008.04.027. Epub 2008 Jun 11. Schizophr Res. 2008. PMID: 18550339 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters